article thumbnail

Avalon Ventures Gets Commitments Of $103M In New, $300M Fund

socalTECH

La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. READ MORE>>.

Avalon 100
article thumbnail

Avalon Ventures Closes $200M Fund

socalTECH

San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company.

Avalon 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ScoreStream Connects Into Amazon Alexa

socalTECH

San Diego-based crowdsourced local sports information provider ScoreStream , led by technology vet Derrick Oien, says it has connected its information into Amazon Alexa. ScoreStream's venture backers include Intel Capital, Avalon Ventures, Sinclair Broadcasting, R/GA and Verizon Ventures. READ MORE>>.

Avalon 113
article thumbnail

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. Bregua Corp.,

Avalon 40
article thumbnail

COI Pharmaceuticals Gets $576M Exit

socalTECH

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124
article thumbnail

Avelas Biosciences Gains $7.65M For Tumor Visualization

socalTECH

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients.

Avalon 138
article thumbnail

Avelas Biosciences Raises $6.85M

socalTECH

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.

Avalon 138